Drug Trial Radar · NCT01657448
Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria
Last checked: Nov 20, 2026Latest source record: Jul 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
316
Actual
Start
Jun 27, 2016
Primary completion
Nov 21, 2016
Study completion Dec 22, 2017
Sponsor
- Lead sponsor
- EMSIndustry
- Sponsor type
- Industry
- First posted
- Aug 6, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of the combination of Methenamine + Methylthioninium chloride compared to phenazopyridine (comparator product) in the symptomatic relief of dysuria.
Conditions
- Dysuria
Interventions
Methenamine and Methylthioninium chlorideDrug
• Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days
PhenazopyridineDrug
• Ingesting two (02) tablets of the drug with a glass of water, every 8 hours for 3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of treatment in the symptomatic relief of dysuriaTime frame: 3 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
AFIP
São Paulo, Brazil
Savmed Clinica Médica S/C Ltda.
São Paulo, Brazil
Centro de Medicina Reprodutiva Carlos Isaia Filho Ltda
Porto Alegre, Rio Grande do Sul, Brazil
Marcio Antonio Pereira Clinica de Endocrinologia
São José dos Campos, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.